- In March 2023, Bionano Genomics, Inc. announced the release of the first study to explore the use of optical genome mapping (OGM) for detecting rare structural variants (SVs) that may play a role in the development of Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome. MRKH is a type of Müllerian agenesis, a condition affecting approximately 1 in 4,500 females, which impacts the reproductive system and may affect the ability to carry a pregnancy
